In compound feed manufacturing, menadione sodium bisulfite is metered into vitamin-mineral premixes at a concentration calculated from the intended premix inclusion rate. At a 0.5% premix usage rate, the premix concentration is set between 0.4 g/kg and 1.2 g/kg, delivering 2.0–6.0 mg/kg complete feed for poultry and swine. This range is not a single minimum requirement; it compensates for coccidiostat stress responses in broilers, sulfonamide-related interference in nursery pigs, and the variability of intestinal menaquinone synthesis in high-density confinement systems. Compliance is governed by Regulation (EC) No 1831/2003, where menadione sodium bisulfite is registered as a nutritional additive with identification code 3a711, and by feed safety criteria for heavy metals, dioxins, and polychlorinated biphenyls under the same framework. In the premix room, MSB is preblended with ground calcium carbonate at a 1:4 ratio in a drum tumbler for 10 min, then discharged into a horizontal ribbon mixer with a fill ratio of 60–70% and mixed for 8–12 min until the coefficient of variation for menadione concentration, determined by HPLC with UV detection at 254 nm, is below 5%. For pelleted compound feed, the mash is conditioned at 70–85 °C for 30–60 s and pressed through a ring die with an L/D ratio of 8:1 to 10:1. Uncoated MSB retention drops by 10–25% under those conditions; feed formulators apply a processing overage of 15–20% or switch to spray-congealed MSB on a starch-silica carrier. Direct contact between MSB and choline chloride or acidic trace mineral packages should be limited to 72 h in stored premixes because moisture exchange and redox reactions accelerate bisulfite cleavage. Terminal products include broiler finisher pellets, layer crumble, swine nursery pellets, granular premixes, and vitamin-mineral premixes for on-farm mixing.

Why Does Water Hardness and pH Control Determine Drinking Water Soluble Powder Stability?

Menadione sodium bisulfite for drinking water application is formulated as a free-flowing soluble powder containing 50–60% active vitamin K3 by weight, lactose monohydrate, citrate buffer, and sodium metabisulfite as antioxidant. The final drinking water target for routine poultry supplementation is 2.0–4.0 mg/L menadione sodium bisulfite; short-term veterinary intervention in pigs and broilers may rise to 8.0 mg/L, but only when water intake and body weight are monitored. Dissolution is run in an opaque high-density polyethylene stock tank at 10 g/L concentration, with water hardness maintained below 150 mg/L CaCO₃ and pH between 5.5 and 6.5; alkaline borehole water above pH 7.2 accelerates bisulfite dissociation and causes free menadione precipitation. The stock solution is drawn by a diaphragm dosing pump at 0.2–1.0 L/h through black polyethylene pipeline into the main drinking line, with a contact time below 6 h to limit light-driven photodegradation. Citrate buffer at 2.0–3.0 g/L is added to control pH drift, and sodium metabisulfite at 0.5–1.0 g/L is included as an oxygen scavenger; both are released from a common powder carrier during mixing. Compliance for the soluble powder is covered by Regulation (EC) No 1831/2003 identification code 3a711, and hygiene of the drinking water application is assessed under the farm HACCP plan. Terminal products include 100 g and 1 kg water-soluble powder sachets, oral solution bottles, and liquid supplement concentrates for swine drinking water systems.

Aqueous Injectable Menadione Sodium Bisulfite: Sterilization Limits and Vial Headspace Requirements

Aqueous injectable processing requires the API to be dissolved in water for injection at 10.0 g/L, with a formulation addition ratio of 1.2 g/L anhydrous citric acid and 2.0 g/L sodium metabisulfite. The solution pH is adjusted to 3.0–3.5 with sterile hydrochloric acid or glycine buffer before membrane filtration through a 0.22 μm PVDF filter. Terminal sterilization by saturated steam autoclaving at 121 °C for 15 min is feasible only when headspace oxygen is displaced by nitrogen to below 2%; otherwise the bisulfite adduct undergoes oxidative cleavage and free menadione precipitates as a yellow solid. If the pH drifts above 4.0, assay loss measured by reverse-phase HPLC at 254 nm exceeds 5% over the sterilization cycle. Aseptic filtration is therefore preferred for batches with high levels of sodium metabisulfite because heat exposure at 121 °C reduces assay by 2–4% even under nitrogen. Compliance for veterinary injectable finished products is governed by Directive 2001/82/EC, EudraLex Volume 4 for Good Manufacturing Practice, and the European Pharmacopoeia tests for bacterial endotoxins and particulate contamination. The API manufacturing segment falls under ICH Q7. The finished products are filled into 50 mL, 100 mL and 250 mL multi-dose vials, or 10 mL amber glass ampoules, and are indicated for intramuscular or subcutaneous use in authorized target species. Intravenous administration is excluded in routine farm practice because species-specific pharmacokinetic data are limited and the aqueous vehicle pH is below the preferred range for systemic infusion. Menadione sodium bisulfite injection is not a first-line antidote for anticoagulant rodenticide poisoning in dogs and cats; phytonadione remains the licensed alternative in those species.

Dry granulation followed by direct compression governs production of menadione sodium bisulfite tablets and capsules because the bisulfite adduct is moisture-labile and wet granulation with water or ethanol increases the moisture content above 2.0%, which triggers degradation during tray drying at temperatures above 45 °C. Tablet cores are formulated with 10–25 mg menadione sodium bisulfite for small-animal oral supplements and 50 mg for calf or piglet tablets; large-animal ruminal boluses contain 150–300 mg in a sustained-release wax matrix. The compression blend uses microcrystalline cellulose PH102, anhydrous lactose, croscarmellose sodium at 2.0–4.0%, and magnesium stearate at 0.5–1.0%. Compression force is maintained between 8–14 kN to achieve tablet hardness of 60–100 N, while friability is held below 1.0% per USP 905. Capsule filling for low-dose strengths uses a tamping pin machine with powder bed moisture below 2.0% and relative humidity below 35%. The terminal products include two-piece hard gelatin capsules, oval tablets, and large-animal boluses. Compliance for these oral veterinary dosage forms is governed by Directive 2001/82/EC, GMP Annex 13 for investigational veterinary products where relevant, USP 905 uniformity of dosage units, and USP 701 disintegration criteria. The main incompatibility is dicalcium phosphate dihydrate, which raises the microclimate pH above 6.0; formulations using this filler show assay loss above 10% in accelerated stability studies at 40 °C and 75% RH for 30 d.

Spray-dried milk replacer and oral drench powders require a carrier system that isolates menadione sodium bisulfite from fat oxidation and high droplet temperatures. The compound is added at 1.5–3.0 mg/kg dry matter in calf and lamb milk replacers, which corresponds to 0.05–0.12 mg/kg body weight per day depending on age and replacement rate. Manufacturing begins with microencapsulation of MSB in a hydrogenated vegetable fat or starch-maltodextrin matrix at a melt temperature of 40–60 °C; the resulting microcapsules are blended into the dry mix before spray drying. The spray dryer inlet temperature is set at 160–180 °C, outlet temperature at 70–85 °C, and the final powder moisture is specified below 3.0%. Copper sulfate, zinc sulfate, and choline chloride are segregated in separate premix fractions because their free moisture and redox activity accelerate menadione loss in the finished bag. The final powder is packed in foil-lined multiwall paper bags with an oxygen barrier of ≤0.1 cm³/m²/24 h. Compliance falls under Regulation (EC) No 1831/2003 with identification code 3a711, and the milk replacer itself is subject to salmonella controls consistent with ISO 6579-1:2017 or equivalent regional standards. Terminal products include calf milk replacer powders, lamb milk replacer, oral drench powders reconstituted at 200 g/L before gavage, and medicated milk replacer for swine neonates.

When High-Shear Extrusion Degrades Uncoated Menadione, Vacuum Coating Controls Recovery in Dry Pet Food and Aquafeed

When high-shear extrusion degrades uncoated menadione sodium bisulfite, vacuum coating controls recovery in dry pet food and aquafeed. Complete extruded diets are usually formulated to 0.5–2.0 mg/kg dry matter for dogs and cats, and 1.0–2.5 mg/kg dry matter for farmed fish and shrimp. The preconditioner operates at 90–95 °C with 15–20% added moisture before extrusion at specific mechanical energy input of 150–250 kJ/kg; under these conditions uncoated MSB added pre-extruder may lose 20–35% of assay because of shear heating, pressure drop, and steam stripping. The standard manufacturing route therefore adds a menadione-containing vitamin premix after extrusion through a vacuum coater at an absolute pressure of 0.6–0.8 bar with soybean oil or fish oil at 4–8% coating level. The coating tumbler holds pellets at 40–50 °C for 8–12 min, and the oil carrier is dosed through a nozzle with a mean droplet size of 100–200 μm. Post-coating MSB recovery exceeds 90% at filled vacuum coater scale for dry dog and cat kibble and for aquafeed pellets in the 2–6 mm diameter range. Compliance for pet food is anchored to AAFCO Official Publication 2024 model regulations and Regulation (EC) No 1831/2003 for feeds sold in the European Union. Terminal products include extruded dog kibble, cat kibble, tilapia and carp pellets, and shrimp nursery feeds. Uncoated menadione addition pre-extruder is not considered robust for aquafeed lines running above 120 °C barrel temperatures, and process validation requires assay testing after the dryer rather than before extrusion.